Clinical Trial Update: A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial update on thymoglobuline induction therapy in adult recipients of donated after cardiac death kidney transplants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Dysfunction

Drugs mentioned

• Thymoglobuline (Antithymocyte globulin)

Snippet

Sponsor: Sanofi | Conditions: End-stage Renal Disease | Phase 4 | Status: COMPLETED